218 related articles for article (PubMed ID: 25179752)
41. Prevalence of antifolate drug resistance markers in Plasmodium vivax in China.
Huang F; Cui Y; Yan H; Liu H; Guo X; Wang G; Zhou S; Xia Z
Front Med; 2022 Feb; 16(1):83-92. PubMed ID: 35257293
[TBL] [Abstract][Full Text] [Related]
42. Lack of quadruple and quintuple mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates from Brazilian endemic areas.
Gomes LR; Lavigne A; Brasil P; Peterka CL; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz MF
Mem Inst Oswaldo Cruz; 2019 Feb; 114():e180425. PubMed ID: 30726345
[TBL] [Abstract][Full Text] [Related]
43. Plasmodium vivax dhfr mutations among isolates from malarious areas of Iran.
Zaman J; Shahbazi A; Asgharzadeh M
Korean J Parasitol; 2011 Jun; 49(2):125-31. PubMed ID: 21738267
[TBL] [Abstract][Full Text] [Related]
44. Characterization of drug resistance genes in Indian Plasmodium falciparum and Plasmodium vivax field isolates.
Narang G; Jakhan J; Tamang S; Yadav K; Singh V
Acta Trop; 2024 Jul; 255():107218. PubMed ID: 38636585
[TBL] [Abstract][Full Text] [Related]
45. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
Marfurt J; de Monbrison F; Brega S; Barbollat L; Müller I; Sie A; Goroti M; Reeder JC; Beck HP; Picot S; Genton B
J Infect Dis; 2008 Aug; 198(3):409-17. PubMed ID: 18582193
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of drug resistance-associated gene mutations in Plasmodium vivax in Central China.
Lu F; Wang B; Cao J; Sattabongkot J; Zhou H; Zhu G; Kim K; Gao Q; Han ET
Korean J Parasitol; 2012 Dec; 50(4):379-84. PubMed ID: 23230341
[TBL] [Abstract][Full Text] [Related]
47. Molecular epidemiology of Plasmodium vivax anti-folate resistance in India.
Prajapati SK; Joshi H; Dev V; Dua VK
Malar J; 2011 Apr; 10():102. PubMed ID: 21513569
[TBL] [Abstract][Full Text] [Related]
48. Polymorphism of Antifolate Drug Resistance in
Zeng W; Wang S; Feng S; Zhong D; Hu Y; Bai Y; Ruan Y; Si Y; Zhao H; Yang Q; Li X; Chen X; Zhang Y; Li C; Xiang Z; Wu Y; Chen F; Su P; Rosenthal BM; Yang Z
Front Cell Infect Microbiol; 2021; 11():683423. PubMed ID: 34249776
[TBL] [Abstract][Full Text] [Related]
49. Plasmodium vivax in the Democratic Republic of East Timor: Parasite prevalence and antifolate resistance-associated mutations.
de Almeida A; Rosário VE; Henriques G; Arez AP; Cravo P
Acta Trop; 2010 Sep; 115(3):288-92. PubMed ID: 20412783
[TBL] [Abstract][Full Text] [Related]
50. Sequence analysis of genes associated with resistance to chloroquine and sulphadoxine pyrimethamine in P. falciparum and P. vivax isolates from the Bannu district of Pakistan.
Khatoon L; Baliraine FN; Malik SA; Yan G
Braz J Infect Dis; 2013; 17(5):596-600. PubMed ID: 23850323
[TBL] [Abstract][Full Text] [Related]
51. The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014.
Tantiamornkul K; Pumpaibool T; Piriyapongsa J; Culleton R; Lek-Uthai U
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):229-237. PubMed ID: 29677637
[TBL] [Abstract][Full Text] [Related]
52. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.
Mula P; Fernández-Martínez A; de Lucio A; Ramos JM; Reyes F; González V; Benito A; Berzosa P
Malar J; 2011 Aug; 10():214. PubMed ID: 21810256
[TBL] [Abstract][Full Text] [Related]
53. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
[TBL] [Abstract][Full Text] [Related]
54. Genetic polymorphisms in genes associated with drug resistance in Plasmodium vivax parasites from northeastern Myanmar.
Huang F; Li S; Tian P; Pu LJS; Cui Y; Liu H; Yang L; Bi DY
Malar J; 2022 Mar; 21(1):66. PubMed ID: 35241080
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of polymorphisms in antifolate drug resistance molecular marker genes pvdhfr and pvdhps in clinical isolates of Plasmodium vivax from Kolkata, India.
Ganguly S; Saha P; Chatterjee M; Maji AK
Antimicrob Agents Chemother; 2014; 58(1):196-200. PubMed ID: 24145518
[TBL] [Abstract][Full Text] [Related]
56. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.
Rungsihirunrat K; Na-Bangchang K; Hawkins VN; Mungthin M; Sibley CH
Am J Trop Med Hyg; 2007 Jun; 76(6):1057-65. PubMed ID: 17556611
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.
Tjitra E; Baker J; Suprianto S; Cheng Q; Anstey NM
Antimicrob Agents Chemother; 2002 Dec; 46(12):3947-53. PubMed ID: 12435700
[TBL] [Abstract][Full Text] [Related]
58. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.
Mekonnen SK; Aseffa A; Berhe N; Teklehaymanot T; Clouse RM; Gebru T; Medhin G; Velavan TP
Malar J; 2014 Jun; 13():244. PubMed ID: 24964730
[TBL] [Abstract][Full Text] [Related]
59. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
Spalding MD; Eyase FL; Akala HM; Bedno SA; Prigge ST; Coldren RL; Moss WJ; Waters NC
Malar J; 2010 Nov; 9():338. PubMed ID: 21106088
[TBL] [Abstract][Full Text] [Related]
60. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
